Trade Acurx Pharmaceuticals, Inc. - ACXP CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.04 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023679% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001457% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 0.39 |
| Open | 0.39 |
| 1-Year Change | -80.88% |
| Day's Range | 0.39 - 0.39 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Mar 31, 2025 | 0.39 | 0.00 | 0.00% | 0.39 | 0.39 | 0.39 |
| Mar 28, 2025 | 0.39 | 0.00 | 0.00% | 0.39 | 0.39 | 0.39 |
| Mar 27, 2025 | 0.40 | 0.00 | 0.00% | 0.40 | 0.41 | 0.39 |
| Mar 26, 2025 | 0.40 | -0.01 | -2.44% | 0.41 | 0.42 | 0.40 |
| Mar 25, 2025 | 0.41 | 0.00 | 0.00% | 0.41 | 0.42 | 0.41 |
| Mar 24, 2025 | 0.41 | 0.01 | 2.50% | 0.40 | 0.41 | 0.40 |
| Mar 21, 2025 | 0.40 | 0.00 | 0.00% | 0.40 | 0.41 | 0.39 |
| Mar 20, 2025 | 0.40 | 0.01 | 2.56% | 0.39 | 0.41 | 0.39 |
| Mar 19, 2025 | 0.39 | 0.00 | 0.00% | 0.39 | 0.39 | 0.39 |
| Mar 18, 2025 | 0.40 | -0.05 | -11.11% | 0.45 | 0.46 | 0.40 |
| Mar 17, 2025 | 0.45 | -0.01 | -2.17% | 0.46 | 0.47 | 0.44 |
| Mar 14, 2025 | 0.44 | 0.01 | 2.33% | 0.43 | 0.44 | 0.43 |
| Mar 13, 2025 | 0.43 | -0.01 | -2.27% | 0.44 | 0.44 | 0.42 |
| Mar 12, 2025 | 0.43 | -0.01 | -2.27% | 0.44 | 0.45 | 0.42 |
| Mar 11, 2025 | 0.43 | -0.01 | -2.27% | 0.44 | 0.44 | 0.41 |
| Mar 10, 2025 | 0.42 | -0.02 | -4.55% | 0.44 | 0.44 | 0.41 |
| Mar 7, 2025 | 0.44 | 0.00 | 0.00% | 0.44 | 0.47 | 0.43 |
| Mar 6, 2025 | 0.62 | 0.02 | 3.33% | 0.60 | 0.64 | 0.58 |
| Mar 5, 2025 | 0.62 | -0.01 | -1.59% | 0.63 | 0.64 | 0.61 |
| Mar 4, 2025 | 0.60 | -0.04 | -6.25% | 0.64 | 0.65 | 0.58 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Acurx Pharmaceuticals, Inc.
Acurx Pharmaceuticals, LLC, a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The company is also developing ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumoniae. The company was founded in 2017 and is based in Staten Island, New York.| Industry: | Biotechnology & Medical Research (NEC) |
259 Liberty Avenue
STATEN ISLAND
NEW YORK 10305
US
News
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025
Coffee price forecast: 2025-2030 third-party coffee target
Coffee prices have cooled considerably in the past few months. Is a rebound in store or will they continue to fall?
09:42, 12 March 2025
The Simpsons predicted XRP to hit $589: Has the show got it right again?
Did the animated TV show predict a breakout for the XRP cryptocurrency?
11:00, 11 March 2025
Rolls-Royce share price forecast: third- party price target
Our Rolls-Royce share price forecast looks at the outlook for the FTSE 100-listed engineering company after a tough few years.
14:58, 10 March 2025
Gasoline petrol price forecast 2025-2030: Third-party price target
Discover third-party gasoline (petrol) price predictions for 2025 and beyond, with analyst targets, historical prices, and trading strategies.
10:27, 3 March 2025
USD forecast - third party data round up
The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.
10:02, 27 February 2025
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025People also watch
Still looking for a broker you can trust?
Join the 710,000+ traders worldwide that chose to trade with Capital.com